Infinity Pharmaceuticals Inc (INFIQ)
0.00
USD |
OTCM |
May 17, 16:00
Infinity Pharmaceuticals Gross Profit Margin (Quarterly): 39.62% for June 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 39.62% |
| March 31, 2023 | 39.67% |
| December 31, 2022 | 39.78% |
| September 30, 2022 | 39.75% |
| June 30, 2022 | 39.65% |
| March 31, 2022 | 39.72% |
| December 31, 2021 | 39.69% |
| September 30, 2021 | 39.72% |
| June 30, 2021 | 39.84% |
| March 31, 2021 | 39.61% |
| December 31, 2020 | 39.68% |
| September 30, 2020 | 39.72% |
| June 30, 2020 | 39.72% |
| March 31, 2020 | 39.72% |
| December 31, 2019 | 39.94% |
| September 30, 2019 | 39.65% |
| June 30, 2019 | 39.69% |
| March 31, 2019 | -215.6% |
| December 31, 2018 | 52.74% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 |
| Date | Value |
|---|---|
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
39.61%
Minimum
Mar 2021
39.94%
Maximum
Dec 2019
39.72%
Average
39.72%
Median
Sep 2020
Gross Profit Margin (Quarterly) Benchmarks
| Athersys Inc | -- |
| Merck & Co Inc | 77.56% |
| MEI Pharma Inc | -- |
| Humanigen Inc | -- |
| Bristol-Myers Squibb Co | 75.29% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -99.01% |
| Profit Margin (Quarterly) | -1.71K% |
| Operating Margin (Quarterly) | -1.74K% |
| Return on Net Operating Assets | -1.19K% |